Abu Dhabi's Mubadala Investment Company completed the Kelix bio acquisition in September. Photo: Mubadala
Abu Dhabi's Mubadala Investment Company completed the Kelix bio acquisition in September. Photo: Mubadala
Mubadala’s Kelix bio acquires GHH’s pharma assets to expand its life sciences portfolio
UAE-based GHH is a healthcare division of Yas Holding investment company
